Dr Dandamudi was trained in the West Midlands and is currently a Senior Consultant Clinical Oncologist at Nuffield Health Wolverhampton Hospital, Royal Wolverhampton NHS Trust and Dudley Group of Hospitals. He specialises in Breast, Prostate, Bladder and Renal cancers with a vast experience and expertise in systemic chemotherapy, Immunotherapy, novel agents, state of the art Radiotherapy techniques and Life Style Medicine.
He is a Clinical Lead
for Radiotherapy, Oligometastatic Stereotactic Ablative Body Radiotherapy
(SABR), Post graduate trainer and Royal College of Radiologists (RCR) Final
FRCR Examiner, Honorary Senior Lecturer for Undergraduate Medical students at
the University of Birmingham.
Clinical Oncology including Breast, Prostate, Bladder and Renal Cancers
Treatments and tests offered by Dr Ravi Dandamudi at Nuffield Health
Principal Investigator (PI)Breast Trials-OPTIMA Study;
POETIC-A Study Bladder Trial: IMMU-132-13
- MRCP (UK)
Other posts held
- Senior Consultant Clinical Oncologist at Royal Wolverhampton Trust
- Senior Consultant Clinical Oncologist at Dudley Group of Hospitals
Insurers Dr Ravi Dandamudi works with
Dr Ravi Dandamudi works with the following private medical insurance providers:
- Aviva Health
- AXA Health
- AXA - Global Healthcare
- Benenden Health
- Bupa On Demand
- CS Healthcare
- The Exeter Friendly
- Freedom Health
- Medical Care Direct
- Tesco Bank
- Universal Provident
- Vitality Health (Pru Health)
- Westfield Health WPA
Dr Ravi Dandamudi does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Ravi Dandamudi does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Ravi Dandamudi does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.